Table 3 Outcomes of the 12 patients with AS-AIH treated with corticosteroids
From: Clinical characteristics and treatment outcomes of acute severe autoimmune hepatitis
Patients | Days before treatment (days) | Changes (Δ) of Day-3 postcorticosteroid treatment | Alive (Y/N) | Relapse (Y/N) | Follow-up period (months) | ||
|---|---|---|---|---|---|---|---|
Δ ALT (IU/L) | Δ TBIL (μmol/L) | Δ INR | |||||
1 | 20 | −65 | −41 | −0.08 | Y | N | 75 |
2 | 7 | −102 | −10.1 | −0.25 | Y | N | 117 |
3 | 10 | −47 | −45 | −0.13 | Y | N | 108 |
4 | 15 | −21 | −12.8 | −0.01 | Y | N | 25 |
5 | 30 | −201 | −37 | + 0.02 | Y | N | 61 |
6 | 20 | −146 | −60.4 | −0.29 | Y | N | 29 |
7 | 40 | −15 | −2.5 | −0.5 | Y | N | 44 |
8 | 10 | −382 | −40.3 | −0.34 | Y | N | 24 |
9 | 8 | −78 | −2.3 | + 0.03 | Y | N | 66 |
10 | 30 | −34 | −21.6 | + 0.02 | Y | Y | 28 |
11 | 60 | −12 | + 32 | + 0.25 | N | ||
12 | 70 | + 37 | + 66.9 | + 0.01 | N | ||